Anthracycline extravasations: Prevention and management

British Journal of Nursing

Volumn 20, Issue 17 SUPPL., 2011, Pages

  Roe, Helen ^a  

^a Lillyhall Business Centre   (United Kingdom)

Author keywords

Anthracyclines; Antidotes; Chemotherapy; Extravasation; Management; Vesicant

Indexed keywords

EID: 80053392675     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2011.20.sup10.s16     Document Type: Article

References (22)

1. Alley E, Green R, Schuchter L (2002) Cutaneous toxicities of cancer therapy. Curr Opin Oncol 14(2): 212-6 (Pubitemid 34235056)
2. Bertelli G, Dini D, Forno G et al (1993) Dimethylsulphoxide and cooling after extravasation of antitumour agents. Lancet 341(8852): 1098-9 (Pubitemid 23114441)
3. Bertelli G, Gozza A, Forno GB et al (1995) Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13(11): 2851-5
4. Dougherty L (2008) IV therapy: recognizing the differences between infiltration and extravasation. Br J Nurs 17(14): 896, 898-901
5. Dougherty L (2010) Extravasation: prevention, recognition and management. Nurs Stand 24(52): 48-55
6. European Oncology Nursing Society (2007) Extravasation guidelines 2007. http://tinyurl.com/3ge5oba (Accessed 2 September 2011)
7. Gault DT (1993) Extravasation injuries. Br J Plast Surg 46(2): 91-6 (Pubitemid 23116051)
8. Jordan K, Behlendorf T, Mueller F, Schmoll HJ (2009) Anthracycline extravasation injuries: management with dexrazoxane. Ther Clin Risk Manag 5(2): 361-6 Epub
9. Langer S W, Thougaard AV, Sehested M, Jensen PB (2006) Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone. Cancer Chemother Pharmacol 57(1): 125-8 Epub
10. Langer S W, Sehested M, Jensen PB (2009a) A Focus on the Treatment of Anthracycline Extravasation and Tissue Protection. http://tinyurl. com/42r2wgx (Accessed 2 September 2011)
11. Langer SW Sehested M, Jensen PB (2009b) Anthracycline extravasation: a comprehensive review of experimental and clinical treatments. Tumori 95(3): 273-82
12. Langer SW (2010) Extravasation of chemotherapy. Curr Oncol Rep 12(4): 242-6
13. Mouridsen HT, Langer S W, Buter J et al (2007) Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Ann Oncol 18(3): 546-50 Epub (Pubitemid 46359637)
14. Olver IN, Schwarz MA (1983) Use of dimethyl sulfoxide in limiting tissue damage caused by extravasation of doxorubicin. Cancer Treat Rep 67(4):407-8 (Pubitemid 13054443)
15. Olver IN, Aisner J, Hament A, Buchanan L, Bishop J F, Kaplan RS (1988) A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol 6(11):1732-5 (Pubitemid 19089053)
16. Polovich M, Whitford JM, Olsen M (2009) Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. 3rd edn. Oncology Nursing Society, Pittsburgh
17. Roe H (2007) Anthracycline extravasations in clinical practice. http://tinyurl.com/3b8mdfb (Accessed 2 September 2011)
18. Schulmeister L (2011a) Extravasation management: clinical update. Semin Oncol Nurs 27(1): 82-90
19. Schulmeister L (2011b) Extravasation. In: Olver I. ed, The MASCC Textbook of Cancer Supportive Care and Survivorship. Multinational Association for Supportive Care in Cancer Society (MASCC), Hillerød
20. United Kingdom Oncology Nursing Society (2008) UKONS Anthracycline Extravasation Management Guidelines. United Kingdom Oncology Nursing Society, London
21. Wengström Y, Margulies A; European Oncology Nursing Society Task Force (2008) European Oncology Nursing Society extravasation guidelines. Eur J Oncol Nurs 12(4): 357-61
22. Young A, Crowe M, Lennan E et al (2009) Delivery of chemotherapy at planned dose and on time. Cancer Nurs Pract 8(5): 16-9